Skip to main content

Advertisement

Log in

Symptomatic and Palliative Care for Stroke Survivors

  • Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

An Erratum to this article was published on 24 May 2014

Abstract

Stroke is the leading cause of disability and one of the most common causes of death worldwide. Outside the setting of acute management, secondary prevention and stroke rehabilitation, little has been written to address the ongoing symptomatic and palliative needs of these patients and their families. In this literature review, we look beyond secondary prevention with the aim of providing evidence-informed management guidelines for the myriad and often under-recognized symptomatic and palliative care needs of stroke survivors. Some of the most common and disabling post-stroke symptoms that are reviewed here include central post-stroke pain, hemiplegic shoulder pain, painful spasticity, fatigue, incontinence, post-stroke seizures, sexual dysfunction, sleep-disordered breathing, depression and emotionalism. We review the role of caregivers and explore ways to support them and, lastly, remind the reader to be perceptive to the patient’s spiritual needs. The literature is most robust, including controlled trials, for central post-stroke pain and depression. Synthesis and discussion outside these areas are frequently limited to smaller studies, case reports and expert opinion. While some data exists to guide informed decision-making, there is an urgent need to document best practice and identify appropriate clinical standards for the full spectrum of symptoms experienced by stroke survivors. We present the current and established data to aid health care providers in symptomatic and palliative management of stroke survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.

Similar content being viewed by others

References

  1. AHA/ASA. Heart Disease and Stroke Statistics – 2010 Update; 2010.

    Google Scholar 

  2. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711.

    Article  PubMed  Google Scholar 

  3. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–2129.

    Article  PubMed  Google Scholar 

  4. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741–754.

    Article  PubMed  Google Scholar 

  5. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377:1693–1702.

    Article  PubMed  Google Scholar 

  6. Duncan PW, Zorowitz R, Bates B, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005;36:e100–e143.

    Article  PubMed  Google Scholar 

  7. Stevens T, Payne SA, Burton C, Addington-Hall J, Jones A. Palliative care in stroke: a critical review of the literature. Palliat Med. 2007;21:323–331.

    Article  PubMed  CAS  Google Scholar 

  8. Edlund WGG, So Y, Franklin G. Clinical Practice Guideline Process Manual. online; 2004.

    Google Scholar 

  9. WHO. Available at: http://www.who.int/cancer/palliative/definition/en/. Accessed 12/07/2011.

  10. Kehayia E, Korner-Bitensky N, Singer F, et al. Differences in pain medication use in stroke patients with aphasia and without aphasia. Stroke. 1997;28:1867–1870.

    Article  PubMed  CAS  Google Scholar 

  11. Jönsson AC, Lindgren I, Hallström B, Norrving B, Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. J Neurol Neurosurg Psychiatry. 2006;77:590–595.

    Article  PubMed  Google Scholar 

  12. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8:857–868.

    Article  PubMed  Google Scholar 

  13. Leijon G, Boivie J. Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27–36.

    Article  PubMed  CAS  Google Scholar 

  14. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;4:CD005454.

    PubMed  Google Scholar 

  15. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56:184–190.

    Article  PubMed  CAS  Google Scholar 

  16. Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152:1018–1023.

    Article  PubMed  CAS  Google Scholar 

  17. Serpell MG, Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557–566.

    Article  PubMed  CAS  Google Scholar 

  18. Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22:252–260.

    Article  PubMed  CAS  Google Scholar 

  19. Lindgren I, Jonsson AC, Norrving B, Lindgren A. Shoulder pain after stroke: a prospective population-based study. Stroke. 2007;38:343–348.

    Article  PubMed  Google Scholar 

  20. Van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J. The impact of physical therapy on functional outcomes after stroke: what’s the evidence? Clin Rehabil. 2004;18:833–862.

    Article  PubMed  Google Scholar 

  21. Singh JA, Fitzgerald PM. Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010;9:CD008271.

    PubMed  Google Scholar 

  22. Koog YH, Jin SS, Yoon K, Min BI. Interventions for hemiplegic shoulder pain: systematic review of randomised controlled trials. Disabil Rehabil. 2010;32:282–291.

    Article  PubMed  Google Scholar 

  23. Gamble GE, Barberan E, Laasch HU, Bowsher D, Tyrrell PJ, Jones AK. Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke. Eur J Pain. 2002;6:467–474.

    Article  PubMed  Google Scholar 

  24. Lapeyre E, Kuks JB, Meijler WJ. Spasticity: revisiting the role and the individual value of several pharmacological treatments. NeuroRehabilitation. 2010;27:193–200.

    PubMed  Google Scholar 

  25. Shaw LC, Price CI, van Wijck FM, et al. Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain. Stroke. 2011;42:1371–1379.

    Article  PubMed  CAS  Google Scholar 

  26. Appelros P. Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res. 2006;29:329–333.

    Article  PubMed  Google Scholar 

  27. Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA. UK Collaborators of IST. Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial. PLoS One. 2011;6:e16988.

    Article  PubMed  CAS  Google Scholar 

  28. Winward C, Sackley C, Metha Z, Rothwell PM. A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke. 2009;40:757–761.

    Article  PubMed  CAS  Google Scholar 

  29. Flinn NA, Stube JE. Post-stroke fatigue: qualitative study of three focus groups. Occup Ther Int. 2010;17:81–91.

    PubMed  Google Scholar 

  30. McGeough E, Pollock A, Smith LN, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2009:CD007030.

  31. Brioschi A, Gramigna S, Werth E, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243–249.

    Article  PubMed  CAS  Google Scholar 

  32. Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2010:CD006788.

  33. Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28:58–62.

    Article  PubMed  CAS  Google Scholar 

  34. Thomas LH, Cross S, Barrett J, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008:CD004462.

  35. Rao SS, Go JT. Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging. 2010;5:163–171.

    Article  PubMed  Google Scholar 

  36. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617–1622.

    Article  PubMed  CAS  Google Scholar 

  37. Berges S, Moulin T, Berger E, et al. Seizures and epilepsy following strokes: recurrence factors. Eur Neurol. 2000;43:3–8.

    Article  PubMed  CAS  Google Scholar 

  38. Kwan J, Wood E. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev 2010:CD005398

  39. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology. 2006;67:S3–S9.

    Article  PubMed  Google Scholar 

  40. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446–456.

    Article  PubMed  CAS  Google Scholar 

  41. Tamam Y, Tamam L, Akil E, Yasan A, Tamam B. Post-stroke sexual functioning in first stroke patients. Eur J Neurol. 2008;15:660–666.

    Article  PubMed  CAS  Google Scholar 

  42. Kautz DD. Hope for love: practical advice for intimacy and sex after stroke. Rehabil Nurs. 2007;32:95–103.

    Article  PubMed  Google Scholar 

  43. Silver B, McCarthy S, Lu M, et al. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis. 2009;18:381–383.

    Article  PubMed  Google Scholar 

  44. Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake disturbanes in ischemic stroke. Neurology. 2009;73:1313–1322.

    Article  PubMed  Google Scholar 

  45. Chan W, Coutts SB, Hanly P. Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke? Stroke. 2010;41:2973–2975.

    Article  PubMed  Google Scholar 

  46. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.

  47. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689.

  48. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123–130.

    Article  PubMed  CAS  Google Scholar 

  49. Rampello L, Alvano A, Chiechio S, Raffaele R, Vecchio I, Malaguarnera M. An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr. 2005;40:275–285.

    Article  PubMed  CAS  Google Scholar 

  50. Mitchell PH, Veith RC, Becker KJ, et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke. 2009;40:3073–3078.

    Article  PubMed  CAS  Google Scholar 

  51. Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG. Generalized anxiety disorder after stroke. J Nerv Ment Dis. 1993;181:100–106.

    Article  PubMed  CAS  Google Scholar 

  52. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099–1104.

    Article  PubMed  CAS  Google Scholar 

  53. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007:CD005594.

  54. House AO, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2010:CD003690.

  55. Dextromethorphan/Quinidine (nuedexta) for pseudobulbar affect. Med Lett Drugs Ther. 2011;53:46–47

    Google Scholar 

  56. Van den Heuvel ET, de Witte LP, Schure LM, Sanderman R. Meyboom-de Jong B. Risk factors for burn-out in caregivers of stroke patients, and possibilities for intervention. Clin Rehabil. 2001;15:669–677.

    Article  PubMed  Google Scholar 

  57. Han B, Haley WE. Family caregiving for patients with stroke. Review and analysis. Stroke. 1999;30:1478–1485.

    Article  PubMed  CAS  Google Scholar 

  58. Kalra L, Evans A, Perez I, et al. Training carers of stroke patients: randomised controlled trial. BMJ. 2004;328:1099.

    Article  PubMed  Google Scholar 

  59. Puchalski C, Ferrell B, Virani R, et al. Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med. 2009;12:885–904.

    Article  PubMed  Google Scholar 

  60. Ehman JW, Ott BB, Short TH, Ciampa RC, Hansen-Flaschen J. Do patients want physicians to inquire about their spiritual or religious beliefs if they become gravely ill? Arch Intern Med. 1999;159:1803–1806.

    Article  PubMed  CAS  Google Scholar 

  61. Quill TE, Lo B, Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997;278:2099–2104.

    Article  PubMed  CAS  Google Scholar 

  62. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351–359.

    Article  PubMed  CAS  Google Scholar 

  63. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829–1832.

    Article  PubMed  CAS  Google Scholar 

  64. Li LT, Wang SH, Ge HY, Chen J, Yue SW, Yu M. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post- stroke depression. J Altern Complement Med. 2008;14:841–846.

    Article  PubMed  Google Scholar 

  65. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347–351.

    Article  PubMed  CAS  Google Scholar 

  66. Murray V, von Arbin M, Bartfai A, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708–716.

    Article  PubMed  CAS  Google Scholar 

  67. Robinson RG, Jorge RE, Clarence-Smith K. Double-blind randomized treatment of poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci. 2008;20:178–184.

    Article  PubMed  CAS  Google Scholar 

Download references

Financial Disclosures/Potential Conflicts of Interest

CJ Creutzfeldt, none; RG Holloway, consultancy with American Academy of Neurology (Associate Editor, Neurology Today) and Milliman Guideline, Inc. (Reviewer, Neurology Guidelines); M Walker, none.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claire J. Creutzfeldt MD.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s11606-014-2876-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Creutzfeldt, C.J., Holloway, R.G. & Walker, M. Symptomatic and Palliative Care for Stroke Survivors. J GEN INTERN MED 27, 853–860 (2012). https://doi.org/10.1007/s11606-011-1966-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-011-1966-4

KEY WORDS

Navigation